Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
There's an imaginary "phase II partner" now too?
Sure a lot of "stuff" this company has going on- all except the part that none of it's actually really occurring or taking place?
What am I missing here? What "partner"?
In what SEC filing has that been announced- along with all these other "major events" that are being talked up, but don't actually exist in reality?
Bamm, BMAK is back- like always, on the day it's going deep red.
And it just posted at .01, down 16.67% which is below the current bid?? That's twice today it looks like an order filled below even the present Bid? That's weird?
BMAK had been sitting way out on the Level II yesterday, even all this AM.
Now, they just slid right in on the dropped Bid/Ask, always one Level off, on the Ask, with you got it, a 10K share block.
BMAK now parked on the Ask w/ 10K shares at .011
Just like that. Amazing IMO.
http://www.otcmarkets.com/stock/BHRT/quote
Like BMAK just put the "cap" on probably for the day at .011 ??
The Bid/Ask is loaded heavy on the Ask today, to the sell side then.
"Crash (< 0.01 USD) coming soon???"
It's a very real possibility IMO. It's been doing more trading sub 1 cent recently on higher volume days than the volume it does on the days it pops its head back above 1 cent- this seems to be the new "normal" range perhaps? And all the PR and "presentations" or "conference call" or whatever hasn't budged it- not a bit that I can see.
There is just a massive amount of low priced share overhang on this one now (they diluted out approx 300 MILLION shares just from 2013 to 2014 and about 50 million in just the last 3 months or so- see recent SEC 8-K filing showing now past 600 MILLION shares and compare to last filed 10-Q which covered share count up to early Nov 2014).
Notice, it just printed that 11 AM Eastern (approx time) near perfect red sell spike on the daily chart- about a 400K perfect round lot share sell looks like. Almost every day now for weeks, like one can practically set their watch to it IMO. Always a round lot big sell lately- like 200K up to about 600K or so near perfect round lots. Almost the same time every day it seems - for weeks now.
The MM's on this one now- seem to be able to drop it like a rock using just very small dollar vol sell orders. Sometimes it doesn't move much on 400K shares sold, but then later will drop like 12% or more in a blink on maybe a 10K share block being sold- like barely $150 bucks worth.
It's definitely real, real weak and highly volatile in here for since at least Jan 2015 IMO. About as wild a ride as I can remember. Many trips to sub 1 CENT territory starting since Jan. Nothing seems to be abating that yet- the volumes have been extremely high on the down-side days and much lower on any "up" days- the few there have been.
Bid just dropped again now to .011, just barely holding 1 CENT and 100K still on the Ask and only about 34K on the Bid. Weak.
My 2 cents
They just took it RED on a tiny, tiny sell order- looked like "maybe" 10K shares worth?
That's about $120 bucks worth and they wiped out the AM gains. The AM buy/green order looked like over a 600K share spike on the daily chart- which took it to the Ask, green about plus 3.3%. 650K or so shares green, a buy order that was probably about $8,000 bucks worth.
Now, a single sell order of maybe $120 bucks or so and it's going back to the red. Wow.
Ask just dropped down at the same time too- now at .0119 and Bid back to just barely over 1 CENT at .0108 (with a 100K shares now sitting on the Ask and just 16K on the Bid). It also shows "day's range" as being .01 on the low side? I did see a quick -12% or something flash by earlier- like maybe it actually printed an order at .01? That was strange?
Breaking the 50 DMA on this one is not as important right now IMO as needing to get all the way back over the 200 DMA. As the 50 DMA and 200 DMA are now inverted on this one- for quite some time (technical pattern known as a "death cross"). The 50 DMA is at about .0120 and 200 DMA is way out at .020.
Pretty amazing IMO, watching these OTC MM's/broker-dealers do what they do.
http://www.otcmarkets.com/stock/BHRT/quote
LOL Quote, " Remember this use to be on the NASDAQ! "
Too funny- yeah it "was" PAST TENSE "on the NASDAQ" in 2008 which is 7 yrs ago now, and lasted about a grand total of 1 yr on the NASDAQ before being de-listed as the price fell pretty much straight down from the day it was listed.
And that was after a horrible IPO- one that raised almost no funds.
http://venturebeat.com/2008/02/20/bioheart-a-new-record-for-ipo-futility/
http://venturebeat.com/2008/02/19/three-yards-and-a-cloud-of-dust-bioheart-makes-it-across-the-ipo-goal-line-but-with-little-to-show-for-its-struggles/
Then came 2009 and forever relegated to the OTC market where it went on to lose about 99.98% of the value of the common shares, and dilute out from about 20 MILLION shares O/S to now well over 600 MILLION shares O/S and climbing, with 2 BILLION shares now authorized (see increase in A/S SEC filing from 2014)
http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aBNETYMPJCg4
Yeah, BHRT "was" once on the NASDAQ, "briefly" and it might as well be ancient history IMO. What that has to do with what happened since or especially their desperate financial condition today, endless use of dilution and toxic convertible debt financing, etc is beyond me?
Most recent BHRT SEC filed 10-Q, PAGE 12:
"NOTE 2 — GOING CONCERN MATTERS
The accompanying unaudited condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying unaudited condensed financial statements, during nine months ended September 30, 2014, the Company incurred an operating loss of $1,247,199 and used $747,184 in cash for operating activities. As of September 30, 2014, the Company had a working capital deficit (current liabilities in excess of current assets) of approximately $10.0 million. These factors among others may indicate that the Company will be unable to continue as a going concern for a reasonable period of time.
The Company’s existence is dependent upon management’s ability to develop profitable operations and to obtain additional funding sources. There can be no assurance that the Company’s financing efforts will result in profitable operations or the resolution of the Company’s liquidity problems."
I mean Radio Shack just filed BK a few weeks ago- but they were "once on the NYSE", on the NYSE pretty much right up until the BK filing occurred, so does it really matter now they were "once" on the NYSE?
BHRT's common stock "performance" from the NASDAQ days to today (they say a picture is worth a 1000 words or something like that)
"It's funny how shorty really underestimated the big pockets"
What "shorty"?? The open short interest on this stock on any given day is for all intents and purposes ZERO. None.
The only people who can and do short 1 cent or sub 1 CENT penny stocks are pro trading desks and the MM's (market makers) themselves- usually the same people who are financing a company like Bioheart via giving them toxic, convertible debt, floorless, financing deals. In BHRT's case they use lots and lots of toxic financing- most recently Asher, Magna, Fourth Man, Danial James and KBM Worldwide or some name like that. Endless convertible debt survival cash deals, just read the most recent SEC 10-Q filing and every SEC 10-Q or 10-K filing going back years.
The only "big pockets" involved with BHRT are the ones financing them continually- the convertible debt hedge fund or toxic loan houses. BHRT has no "big pockets"? BHRT has total assets of about $250K total on their last 10-Q and total cash at the end of that qtr or a pittance of $46K grand total, almost cash broke. What "big pockets" would BHRT have?
If anyone was "shorty" on this stock- then they're the ONLY one who have made money on it more than likely- as the common shares have lost about 99.98% of their value since going public in 2008.
BHRT went public in 2008 at $5.00 a share and rapidly collapsed in price from there- being de-listed from the NASDAQ only 1 yr later, almost to the day in 2009, relegated to trading then on the OTC market.
$5.00 a share to a recent ONE CENT a share is about a 99.98% or more total loss to the common shares. That's this supposed "shorty's" greatest dream come true in life IMO.
Quote: "That email was written by "SuperFeed", also known on this board as "InvestorStemCell" since he owns the website that you are or were clearly signed up as a member of... InvestorStemCell.com.
He himself is a shareholder, and clearly states the article he wrote is in his opinion.
This in no way is a paid penny promotion by Bioheart, but another shareholder giving his opinion. "
I don't believe any of that. How can any of that be proven? How does anyone know who's a shareholder and who's not? How does anyone know who's signed up as a "member" to some website or not, unless they own or work for that website? How? How does anyone know who's been paid a promotion fee or not, etc? Impossible IMO.
Total BS.
Quote: "Has PW set the ultimate trap for the Shorts with the long weekend coming being that the market is closed on Mon Holiday??
"
What shorts? The open short interest on this stock as a percentage of float is essentially ZERO at any given time- it's noise level. There's very little shorting of 6 cent OTC traded stocks. Any daily shorting is just MM's filling orders- they short every single day as part of their normal "making of a market" and to provide liquidity- they then closeout those same short positions often within seconds or minutes, and certainly by end of day. MM's rarely hold any overnight open shorts, almost never.
Also, there has been no "lock up period" ? No such thing even existed.
Also, there is no "quiet period"? I don't even know what that means?
Where's the money coming from? DILUTION from Lincoln- same place it always has.
Also, companies regularly put out "for hire" notices all the time- often never hiring anyone. I've worked for untold number of companies that always showed open positions on Monster or wherever- but never filling them. It's as old as time- it makes the company look "active". So no one knows if they're hiring for real or not.
"There's no disclaimer stating they were paid to write that"
And what, that means it didn't happen? That site is run about as "loose" as they come IMO. Who knows what was paid or not paid- I don't know and I don't think anyone else does either?
It doesn't specifically say they've not or never been "compensated" in some way, does it??
Also, I'm not familiar at all with public company CEO's taking phone calls and/or emails from members of the general public, especially those who often claim to hold, or be preparing to take large positions in the common stock ?
All my experience shows me that CEO's almost never speak to the general public, especially regarding anything to do with the stock- unless under very formal settings such as public conference calls, analysts calls where all get equal access at the same time, etc. I'd like to see if Mark Zuckerberg of Facebook or Steve Cook of Apple can be called and/or emails and asked personal specific questions about the company or its stock or the business operations, let alone expect a response? I'd highly, highly doubt that would ever happen.
That site in question- regularly, as in just recently, makes claims that the "stock is about to be promoted"- I've read it with my own eyes. Now how would that person know that or even speculate on that? How would they know a "promotion" is coming and specifically when it's supposedly coming? I find that extremely troubling- especially when that person is then going to send out emails to a "member base" like Aug08 received, more than likely telling others the "stock is about to be promoted", etc
"The point is you didn't get it from Bioheart directly."
What difference does that make? For example, in 2014 it's well known that Bioheart paid smallcapvoice $5K to "promote" their stock- so anyone getting email bombed from "smallcapvoice" didn't get it "directly from Bioheart" either- but it was all driven behind the scenes by Bioheart and Bioheart's money being paid to the "promoter" and email house.
The email Aug08 received is from a well established, well known "promoter" of BHRT IMO. That penny promotion site even "claims" to have personal contact with the CEO on a regular basic both by phone and email (I can show the posts on that site describing that type of interaction), they host his blog for him (rather than it being hosted on the official BHRT corporate website/server under Bioheart's IT ADMIN control, something that's never made sense to me personally), etc
It's easy to go back years in time and show what I believe would be a long, long time relationship between that penny promoter and Bioheart- w/o even trying hard.
I don't think any penny promotions that I'm familiar with ever come "directly from the company itself" - that's why they use "promoters", it puts a layer between them and the penny promotion. Nothing new there IMO.
"Here's that email"
Why am I not surprised who that penny "promotional" email came from? I had about a 99.98% certainty that's who it was going to turn out to be.
No surprise there. A long time "promoter" of Bioheart- goes way, way, way back on this one.
What's so funny too is how just EPIC WRONG so much of the info in that "promotional email" from that guy was.
Yahoo for instance- was never, ever, ever a "penny stock" as he so falsely claimed. Yahoo went public in April of 1996 with an initial offering price of $24.50 a share and hit a high that trading day of $45 DOLLARS a share, not .43 cents like Gruner stated in that just totally false email promotion. The guy is supposedly promoting stocks in some penny newsletter- but doesn't even understand the effects of forward splits on a stock's price- as in needing to read a split adjusted chart to get a correct price if looking backward in time.
There's so much wrong in that email you got- I could dismantle nearly everything that was in it- and show how incorrect and inaccurate it was.
But no surprise. I had a feeling that's who you'd of gotten a Bioheart promotional hype email from. Not surprised in the slightest.
The 98% LOSS CHART. I'm looking at that chart that shows the 98% LOSS TO COMMON SHARES since they went public. THAT ONE.
It's not "green", it's RED.
It's a ski slope DOWN from $5 a share to a R/S split adjusted 6.x CENTS today. That chart.
$5.00 = 500 cents, there initial public price after morphing into ACTC from the Two Moons Kachina Doll Company of Utah.
500 - 6 cents = 494 cents. 494/500 = .988 X 100 = 98.8% LOSS. That chart. The LOSS chart. The only OCAT chart there is.
http://www.nature.com/news/stem-cell-research-never-say-die-1.9759
Is there any other chart to look at?
All the best.
Yep, RED. Just as was stated. I 100% agree.
All those AM tall tales and the stock is RED. Imagine that?
Guess all those out in the market, the FREE market just aren't smart enough to figure out all these vast, myth based "hypothesis" and imaginary claims and tall tale stories being made and told, eh?
RED. That's the reality.
Trials run on CASH on MONEY and lots of it. Right now, OCAT ain't got it. They got Lincoln and that's about it. And Lincoln ($20 mil or so left) is 1) Highly dilutive and 2) Ain't enough to fund any serious size phase II, FDA quality trial.
That's the reality IMO.
Total BS.
Disagree away. I am looking at level II and also at the past 2 months of trading pattern.
It's barely off the 1 CENT mark on the bid, barely.
Last trade was 11:45 AM Eastern. It's now 12:45 AM Eastern- and it's been parked. That's not an "active" strongly trading stock. ILL-LIQUID and moving like molasses.
There's no sign here of any trend reversal or major uptrend or anything, none.
ONE sell order of "size" and the MM's can sink this faster than one can blink- and they've done it every week now for 2 months.
There is little actual buying pressure right now. The stock is flat-lining for long periods again today, going for 30 minutes to 1 hour w/o a single trade posting. That's largely ill-liquid. There's barely a market "being made" in it today. The MM's just have it trading on an ultra wide spread as is typical for this one when they let it come up a day or two for some air and probably a little short covering from the "big boy" pro trading desks, aka the Ashers and Magnas out there.
There's no strength yet or any sign of a major reversal or uptrend even beginning- not true. The level II doesn't show it and the 3 month chart or daily chart or weekly chart doesn't show it. They just used a single sell order of "maybe" $500 lousy bucks and sunk the price 15%, just like that. That's called being ill-liquid and trading only on the spread.
Micro sell order- just cut the imaginary "30% gain" in half, just like that.
Looks like it wasn't even maybe a $500 dollar sell.
And the stock had been flat-lined, no trades for about the past 1 hour.
That's called "ill-liquid". That's how these MM's "do what they do" on a thin traded nano-cap like this one.
They just used a single $500 or so to whack 15% off this in a blink. It's hard to tell if the trades are even retail have the time- or just some trading desk trading both sides of the Bid and Ask IMO.
I don't think this has seen the last of the sub ONE CENT days by any stretch. It's just got no really buying pressure at all- and hasn't for a long time now. It's been in a sustained 9 month plus downtrend and no sign yet of even close to a reversal of that has happened yet.
The "blog" thingy Quote: "Fundamental shifts in venture capital investment strategies where financial sponsorship is now directed toward commercial or near commercial enterprises has required Bioheart to adapt its mission combining immediate revenue generating opportunities with longer-term development programs."
I don't even know what that's supposed to mean, that CEO "blog" statement? We just passed through and are actually still in, one of the biggest bull markets and "easy money" periods of all human history and certainly of all U.S. stock market history.
Companies have been raising money like water- all kinds of companies in every biz segment, including early stage bio-tech and pharma R&D companies. Raising super tankers full of money. There's no "fundamental shift in venture capital investment strategies" that I'm aware of, none? I'd like to see the academia and market and other research to support such a claim?
Again, money has probably never been easier for companies to raise than in the past few years (other than perhaps the dot com bubble era of 2000)- money is just pouring into companies coffers and Venture funds, hedge funds, etc.
Here's just a few links to bio-tech and pharma related IPOS- companies are raising money like it's coming off a printing press and venture firms are as alive and well as ever before- no sign of any "fundamental shift" blah, blah that I'm aware of, have read of in the financial or academia press, etc.
http://www.fiercebiotech.com/tags/biotech-ipos
Notice the early 2015 IPO capital raises already occurring- those are R&D companies w/ no "revenues"- pure R&D stage biotechs.
http://www.forbes.com/sites/brucebooth/2014/08/04/vc-backed-biotech-ipos-valuations-and-virtuous-cycles/
That's Forbes, one of the most widely read and credible biz mags on the planet.
QUOTE from Forbes:
"As everyone in biotech knows, the last eighteen months have been an unprecedented time in the public capital markets. 2014 is on track to become the best year ever for life science IPOs, topping both 2013 and 2000. Last week was the busiest single week – with eight IPOs – since February 2000. Over 120 life science companies have gone public since the beginning of last year.
This staggering volume of deals has brought nearly $10B of public equity financing to emerging life science players, at attractive prices, which serves as much-needed growth capital to advance their pipelines."
That IMO is 100% the opposite reality of what that "blog" just stated? Totally 100% diametrically opposing statements IMO. And I'd trust Forbes over some "blog" IMO.
http://www.biospace.com/news_subject_all_results.aspx?CatagoryId=40069
http://www.betaboston.com/news/2014/06/18/new-record-set-for-most-massachusetts-biotech-ipos-in-a-year/
http://www.mercurynews.com/60-second-business-break/ci_27202755/biz-break-biotech-ipos-surge-silicon-valley-nationwide
The "claims" in that "blog" thing make ZERO sense IMO and fly completely opposite to what is stated in numerous, numerous highly credible financial articles in the above links. There has never been a better time for raising R&D biotech capital- some of those articles stated in the past "100 years". For pure R&D biotech companies. There's no "fundamental shift" in the venture side of biotech- unless maybe it's been a "shift" to MONEY FLOWING LIKE WATER to good quality biotech companies that the venture firms and investors find worthy of investing in IMO.
"All buys today it appears"
ALL SPREAD trades today it appears- look at the Bid. It's parked barely off of 1 CENT.
This isn't going anywhere. Not when the Bid stays pinned down and it's trading on a 20% spread. No way.
This is exactly what the MM's did several times now for weeks- after they buried it for days, they then took the boot off for a day or two and opened the spread way up- using micro buys on the Ask to "walk it way up" each time.
Until that Bid moves, it's trading only on the spread which means weakness in supposed move "up", not any strength or real underlying buying pressure.
"0.0129 USD. +29%!!!"
Look at the Bid, that's the key - it hasn't budged, it's at .011.
This is the pattern the MM's use. They've got the spread opened up Grand Canyon wide again. Just pull up a chart from Dec 2014 to now.
This is nothing new- they're just setting it up to convert another round of shares IMO.
Nothing more. When the Bid doesn't move in tandem- then there's very little real buying pressure taking place, it's just MM's "working it" back to where they want/need it to be IMO.
Quote: "LOL BYE BYE SHORTY!"??
What "shorty"?? There's essentially ZERO open short interest on this stock at any given time, essentially none. There's no shorting of 1 cent or sub one cent stocks via retail traders?
The stock has traded less than $200 bucks worth this AM, 1 hour into the trading day.
What does something like "Bye Bye Shorty" even mean? What's even supposed to mean when the stock is barely even trading any dollar volume?
It makes zero sense? None. There's no short covering or anything related to some myth based "shorty" happening here? There's almost no buying interest here and no volume. Where? How?
Who exactly is this "shorty" being referred to?
What indicates that's taking place? Again, makes no sense at all IMO.
"0.011 (+10%)!!!"
Yeah, on volume of about $110 bucks worth, almost 1 hour into the trading day.
That ain't exactly "heading up"?? It's barely liquid and barely trading at this point.
Not a good sign. When this one goes "ill-liquid" most times I've ever seen it in the past- it's getting ready to get buried in a blink. With no liquidity, a single sell order of any "size", even like say $1000 or $3000 bucks worth can often bury it like 10% to 20% in a blink. Let alone a serious sell order, which for this ill-liquid a stock is anything really over about $5K dollars, which is noise level money- but can sink this thing like a brick when it's in this flat-lining, thin, highly ill-liquid, super slow trading mode.
Right now, that "up 10%" is on nothing but the spread and as stated, is on a grand total, whopping $110 or so bucks worth, almost 1 hour after market open.
Took till 10:06 Eastern (36 minutes after market open) to post a single 8K share trade.
That's 8K X .011 = $88 bucks worth.
Yep, it's rolling along now, LOL !
But on the sell/dump days like earlier this week, and for the past several weeks, it's been posting single sell orders of 200K to about 600K shares at a single pop and the first trade being placed seconds after market open.
Yeah, this makes sense?
LOL !! Quote, "This one will go in the history books of penny stocks for the most recovery of any stock, in my opinion. People at elite business schools will talk of this success in class in my opinion."
NO. I'd really doubt that. Unless they have a chapter or class on how to lose 99.98% or more of your company's common stock value. I'm not aware of any "elite business school" that teaches a course on penny stocks that have gone sub ONE CENT while diluting their share out to probably ONE BILLION O/S before too much longer here? (I'm really not aware of any elite business school that even discusses or teaches anything on penny, micro-cap stocks, other than maybe a passing mention in some chapter on what not to do? Or maybe a chapter or section on toxic, convertible debt, "floorless" financing and how to do it or run hedge funds to do it- I could see that perhaps being taught at certain "elite" schools, yes.)
This stock has made no imaginary "recovery"?? They're in an unbroken downtrend and making low highs and lower lows, using endless convertible debt (toxic financing deals) for life support cash as recent as Oct of 2014, they're diluting their shares at a furious pace as in 50 million shares from approx Nov 2014 early Feb 2015 (see last 10-Q share count then 8-K proxy vote filing share count), etc What imaginary "recovery" are they supposedly in?
"Elite business schools" talking about BHRT "success"?? That's one of the funniest things I think I've ever heard. Again, I'm not aware of a single course at Harvard or an article in the "Harvard Business Review" that ever discussed some sub one cent penny stock that never had a profit or ROI since its inception in 1999, or one that's declined in price about 99% since going public in 2008 in a horrible IPO that raised almost no funds and then was delisted from the NASDAQ only one short yr later. Uh NO, I highly doubt it. This is not imaginary "elite business school" material IMO. Again, just too funny !
Quote: "They have plenty of buyers at one cent.
I've had a limit buy order set since early morning. Appears no one is willing to SELL for one cent. "
A liquid stock, a "healthy" trading stock with MM's "making a market" does not sit for 23 minutes now w/o a single trade. It means there's essentially no retail buyers or sellers or orders being matched or order flow. It's called ill-liquid.
One anecdote that one person has a "buy order in" doesn't mean by any stretch that there's "plenty of buyers". Not how a market works.
When it takes over 20 minutes for so much as $100 to even trade- then it's gone ill-liquid. If there was truly a "lot of, or plenty of buyers" then the MM's job is the "make a market" and provide liquidity - which is obviously not happening when it sits parked w/o a single trade, not so much as $50 bucks or $100 bucks worth matching up.
My 2 cents.
Zero volume on open? Must be back to "that mode" now maybe for a few days? Over 15 minutes in to trading day and they can't find one buyer to take a nibble at even 1 CENT?
Seems they bury it for 3 or 4 in a row of high vol selling, then let it breathe a tad, then start burying it again- that's the pattern for about 1.5 months now. It's made a lot of trips below ONE CENT now since mid Jan 2015.
There's no support IMO as is being claimed. The Bid on this thing looks to be in free-fall at any given time and from these levels- can make a trip to .007 in a blink, just like in mid Jan.
BMAK is back parked on the Ask this AM, one level off with a perfect 10K share block as always.
Huge volume of 1.5 million to 4 million or more shares on the sell/dump days- and now it can't even post a $100 bucks worth on market open?
This should be interesting today.
Oh, and the "analysis" of a medical RESEARCH and DEVELOPMENT company (by their own definition) cutting its R&D spending to near nothing- as some kind of actual "business model" or "plan" makes zero sense to me- and is certainly not any kind of "analysis" that I'm familiar with? I didn't see a single "analytical" thing in that entire "analysis"? None.
Quote: "Tap into revenues, lower R and D because it makes no sense at this time given the plan. " ???
What? Lower R&D now "because it makes no sense at this time given the plan"??? Huh?
The "plan" just said they "plan" to run TWO trials- one for Myocell known as MARVEL and another for Myocell SDF-1. Running clinical trials for a medical research and development company, last time I checked, is known as R & D.
"trials" expenses are booked as "R & D expenses". Thus, when R&D has been hacked to near zero- there's no way they, BHRT, are running or funding any "trials". It's as simple as that.
Wonder why MIRROR did not "get FULLY FUNDED BY BIOHEART" as originally claimed in it's "PR"- because they hacked out the R&D spending and diverted it to things like paying a few insiders huge base salary increases and also very large cash bonuses- among other places to which they diverted cash (paying off debt to insiders for example).
Here's how it works in medical company business 101: NO R&D spending or expense line entries = NO TRIALS BEING FUNDED OR RUN.
It's pretty straight forward. Just go back in their SEC filings- say like the 10-K from 2008 or 2009 for instance, when they were still running actual FDA quality, fully staffed "medical trials" like MARVEL and REGEN and take a look at how much was being spent on R&D then.
Here, I'll post one now. Oh, and notice, they HAD REVENUES back then. This myth being peddled that "this is the first time Bioheart has EVER had "revenues" is just that, a myth".
http://www.sec.gov/Archives/edgar/data/1388319/000114544310000824/d26454_10k.htm
From the 10-K filing covering yr 2009, PAGE F-4:
REVENUES: $359,800
Expenses:
Research and development: $2,491,189
Marketing, general and administrative: $2,095,292
See that. $2.4 MILLION in R&D spending that yr. Now, in 2014, it's barely gonna crack probably $50K, if even that. $2.4 MILLION in R&D to now maybe $50K. And one wonders why MIRROR or MARVEL never got funded this year, let alone the past several years?
Notice also the Marketing and general and Admin costs (salaries being a big part of that)- in 2009 when they still had a much larger staff and number of employees they had about $2 mil in SG&A for the year.
This year, 2014, with only qty-4 full time employees- that SG&A expense line has exploded up to $3.1 MILLION and the year's not even over yet ($3.1 mil is only 9 month's worth so far). $1,575,000 of that in 2014 is just the salaries and bonuses for just 2 people in the company. That's a little "perspective" IMO.
The statement that "R&D makes no sense now at this point per the plan" - that statement is what makes NO SENSE to me? None?
Quote: "IMO I am looking at the cancellation as extremely positive and bullish for $OCAT going forward. There is NO dilution now. "
The stock symbol is OCAT (there is no such symbol as $OCAT)
Huh, no dilution? Where did this myth come from? It's ALL DILUTION NOW. OCAT is living off of Lincoln. About as dilution based as one can get.
1) Just cause a "slide" at some presentation says "uplist by Q-1, 2015" doesn't mean by any stretch it's a guarantee. That presentation was to a limited audience and there's "safe harbor" and any other number of ways out of it- just like they yanked an offering they "said" was going to happen. They had no pricing power is what I believed from day one- and also the major botch of the we-uplisted-but-oops-never-really-did put FINRA all over these guys which that right there may have snagged the entire offering going forward at least for now.
2) If they tap Lincoln for enough cash to get their positive shareholder equity up where they need it- it's pure dilution. Also, they're surviving off of and living off of Lincoln right now.
There's no "secret" hidden source of funds coming in or any other myths like that- if they had some new cash source or whatever, a "financing deal" then it's a "material event" and would be plastered on a SEC filing and made public.
All that happened was they had a weak offer and it got pulled. Everything else is pure speculation- some of it so far fetched as to be laughable.
Lets play TOSS A BIG COMPANY NAME OUT THERE NOW AND PLAY FANTASY JOINT VENTURE. Amazon sells a lot of Kindles and likes people who read and watch Dvd's and junk- it's HIGHLY LIKELY that Amazon is going to partner or maybe ( I heard a rumor from a guy someplace) that Amazon may even BUY OUT OCAT for like a 1000% premium over the current price.
See, see how easy that was. That "rumor" is as credible as anything I've read here so far since the PR went out that they yanked the offering.
Quote: "Super MONSTER LOaDIng!!! Look at all the volume!! Everyone is jumping on the train before it takes off IMO"
WHAT? It just closed SOLID RED, down 3% on the day with a day's low of .009, or two zeroes after the ole decimal point aka known as SUB ONE CENT (not even a "penny stock" anymore, but a sub one penny stock).
That's called net SELLING. Or known as people JUMPING OFF the train as it's sinking like a brick. The market cap at close today is at about $5.8 dismal million dollars (despite massive recent dilution) with a dip in the AM to as low as barely $5 million.
The volume today is actually lower than it's been on many of the other sell/dump days for the past several weeks- many of those averaging 3 million to as much as 4 million plus shares to the hard down side.
Regardless, it just closed down red again today- that's selling, not net buying. No indication at all of any net volume of buyers "jumping on the train". The daily chart simply does not bear that out as being true.
LOL, Quote: "WOW monster loading IMO !"
What? LOOK at the daily chart- nearly all the volume today was MASSIVE DOWN SIDE SELLING and it was mostly done prior to Noon Eastern.
It's barely traded into the late afternoon- being allowed to "walk back up" a bit on some micro buys.
There's no "monster loading"?? Nothing on the daily chart or level II shows that to be occurring? Where?
Quote: "Things are happening, times are changing... BioHeart is at the forefront of the future of medical treatment."
What does that even mean?
Why's the share price today then dipping to two zeroes after the decimal again, aka SUB ONE CENT?? Why?
The market cap is touching the $5 MILLION mark this AM. $5 million is a pittance for a public traded stock company. Most small, private, family owned businesses would have a total value exceeding $5 million.
And in reality- Bioheart has no intrinsic value at all as it's carrying $10 million in debt against essentially no assets ($250K or so as of the last 10-Q filing) and has essentially no cash reserves. Thus, if liquidated or sold off- it's value is for all intents and purposes zero if not negative. There is no positive shareholder equity at all and it's never produced an ROI in 15 yrs of existence.
How is that "things are happening, time are changing"-what imaginary "forefront of the future of medical treatment" are they supposedly at? Why would they be given a value by the market then of essentially zero (when their debt is accounted for) - if any of that statement was true? Any big, "smart money" investment firms or anyone rushing in here to get a piece of this fantasy of the "future of medical treatment" or whatever the claim is? Even at sub ONE CENT a share- there's been no rush of buying or any real buying pressure in here at all? All they can ever attract so far is the most desperation kind of financing a business can use- the convertible, floorless, toxic debt kind.
I don't understand these slick sounding platitude sentences and "claims" that this is some future miracle blah, blah, blah or whatever- when nothing about the market place proves one iota of that to be true IMO. I don't see it happening- I see a declining market cap and share price and ever rising share count due to massive dilution- that's not the sign of some imaginary grand success by any stretch of an imagination?
"BHRT GOING GOING!"???
Going DOWN steadily. The Bid is sub ONE CENT.
What's going? Where? It's in free fall for over several months now?
Like stepping under a collapsing bridge? It's not even close to a trend reversal, let alone any uptrend. Massive volume days have all been hard to the down side, like today.
It was a lot more than a "CEO interview". Once BHRT stops paying (their $5K per month fee runs out) a lot of what smallcapvoice had posted gets "scrubbed" Orwell style.
At the time of the paid penny promotion- the "disclosure" stated in no uncertain terms that they, smallcapvoice would use email blasts, it's "network" of broker/dealers and penny promoters and "numerous" other means to "promote" the company's stock.
Click on the right side-bar right now on that site and read their "full disclosure" page for any current company they're promoting- it's all the same.
Bid .0091 and Ask now dropped hard to .0092 making lower highs and continually lower lows.
Looks like this big "news" again- just hasn't sunk in or made it to the market yet? Like the other PR, the "presentation" the "projections" and the "plans" and all the rest?
It's down hard today and the volume is up, all to the sell side.
What am I missing here?
Quote: "I can tell you if you received any emails, it is not from Bioheart but from actual pumpers"
Really? Bioheart ran a PAID PENNY PROMOTION last yr- fully disclosed on the penny pump site called "smallcapvoice" which uses "email" among other tools to hype n pump penny stocks.
It was right there on that sites full disclosure page.
http://smallcapvoice.com/blog/5-28-14-smallcapvoice-interview-with-bioheart-inc-bhrt/
smallcapvoice had Bioheart on their "disclosure page" as paying $5K for that penny promotion- more than BHRT spends in a month on R&D now.
BHRT has used paid penny promotion many times in the past- I can find every last link and time and post um. It's not hard to find using search methods.
Quote: "On track for the 10K in March to show over $2-million in revenue for 2014! "
Also "on track" to show LARGER LOSSES from operations than in 2013, despite "revenues" and despite cutting R&D to less than $3K per month, a drop of over $400K in one yr and much more than that over subsequent yrs.
Also, what exactly are they "selling" as products/treatments for use on humans "overseas" and now per their "slide presentation" apparently at a "clinic" in Florida too?? I don't get it per their own SEC filings?
From the Bioheart 10-K, PAGE 39:
"We do not currently have product liability insurance because none of our product candidates has yet been approved for commercialization. While we plan to seek product liability insurance coverage if any of our product candidates are sold commercially, we cannot assure you that we will be able to obtain product liability insurance on commercially acceptable terms, if at all, or that we will be able to maintain such insurance at a reasonable cost or in sufficient amounts to protect against potential losses.
Claims may be made by consumers, healthcare providers, third party strategic collaborators or others selling our products if one of our products or product candidates causes, or appears to have caused, an injury. We may be subject to claims against us even if an alleged injury is due to the actions of others. For example, we rely on the expertise of physicians, nurses and other associated medical personnel to perform the medical procedures and processes related to our product candidates. If these medical personnel are not properly trained or are negligent in using our product candidates, the therapeutic effect of our product candidates may be diminished or the patient may suffer injury, which may subject us to liability. In addition, an injury resulting from the activities of our suppliers may serve as a basis for a claim against us.
We do not intend to promote, or to in any way support or encourage the promotion of, our product candidates for off-label or otherwise unapproved uses. However, if our product candidates are approved by the FDA or similar foreign regulatory authorities, we cannot prevent a physician from using them for any off-label applications. If injury to a patient results from such an inappropriate use, we may become involved in a product liability suit, which will likely be expensive to defend.
These liabilities could prevent or interfere with our clinical efforts, product development efforts and any subsequent product commercialization efforts, all of which could have a material adverse effect on our business."
I don't believe just "being overseas" frees one from liability exposure for medical products/treatments that have not been proven safe for use in humans, per the company's own SEC filings, does it?
I find that very confusing IMO.
"Bioheart Strengthens Management Team with Appointment of Martin E. Schmieg as President of Vetbiologics, Inc. "
I wonder what cash they're gonna use to pay him with? The recent $800K bonuses were paid as "promissory notes" the cash was so low, finishing last qtr with $46K cash against over $2 million in just the most immediate types of debt, "accounts payable" (see most recent 10-Q SEC filing, pages 4 and 5)
Also, in that same, most recent 10-Q filing- they, BHRT are still relying on "related party notes" as in borrowing from themselves basically to pay bills and so forth. Then, in later parts of the same 10-Q, issuing common shares to pay off other "related party notes" which makes no sense to me?
Also, they, BHRT issued many PR's in the past announcing "big hiring" type deals or "teams of experts being brought on" etc- only to never be heard about again IMO, or never seeming to match the later "employee" count" as given in the later SEC filings.
Here's one I remember- where they said they were "beefing up the key staff", but it doesn't jive to me with the last 10-Q that they had 4 full time and 1 part time employee. Cause at the time that PR was issued, they already had 3 employees, 2 of which are always Tomas and Comella of course- so that one never made sense to me either? And one of the announced "key positions" was financial/accounting related- yet Tomas per their SEC filing's own statements acts as sole person responsible for all accounting and financial issues within the company- like they have no financial controller or Sr. accounting position.
Here's that past PR about "adding key staff" - but I don't know where these people ever went as they don't seem to match the later SEC filing "employee counts" IMO?
http://www.marketwired.com/press-release/bioheart-boosts-team-with-regulatory-finance-and-administrative-expertise-otcqb-bhrt-1833174.htm
See that one. "Bioheart Boosts Team With Regulatory, Finance and Administrative Expertise"
But the company is only 4 full time and 1 part time right now- and 2 are Tomas and Comella and they've never mentioned having a "regulatory" or "finance" person since that I can remember?
Or this one:
http://www.bloomberg.com/apps/news?pid=newsarchive&sid=asecNvIZ.xXI
Or this one:
http://globenewswire.com/news-release/2012/02/29/469402/247547/en/Bioheart-Appoints-Advisory-Board-of-Business-and-Financial-Executives.html?print=1
Or this one:
http://globenewswire.com/news-release/2012/01/30/466536/244075/en/Frank-Young-Joins-Bioheart-as-Financial-Consultant.html
Who knows? I guess that Magna line will be tapped to pay this new guy or just more common shares issued to him like all the "related party notes"? I don't get it?
For example, the last 10-Q, PAGE 36 (I'd assume the $800K "notes" are the bonuses paid to Comella and Tomas, meaning they didn't have cash to pay um- so they issue notes w/ interest on um typically and it notes rising accounts payable due and rising accrued, meaning yet to be paid expenses)
"Our use of cash for operations in the nine months ended September 30, 2014 reflected a net loss generated during the period of $1,247,199, adjusted for non-cash items such as stock-based compensation of $407,616, fair value of warrants issued of $136,837, depreciation of $3,745, amortization of debt discounts of $343,592, related party notes payable issued for services of $800,000 and non-cash interest paid of $385,501, loss on change in fair value of derivative liabilities of $61,339, net gain on settlement of debt of $2,272,283. In addition we had a net increase in operating assets of $186,306 and an increase in accrued expenses of $246,486 and in accounts payable of $628,684."
And here, in the same 10-Q filing, one can see them "paying bills" not using cash, but be issuing out common shares of stock- for even "accounts payable" and "consulting services". So again, what are they gonna pay this new "C" level guy with?
PAGE 27 (it's about 9.5 MILLION shares issued for "paying bills" instead of traditional method of using CASH to pay a company's bills. They issue shares like this every qtr for "bill paying", as far back as I can remember in SEC filings)
"Subsequent issuances
On October 3, 2014, the Company issued 514,886 shares of its common stock as payment of $70,521 interest on its Northstar (related party) debt.
In October 2014, the Company issued 1,818,182 shares of its common stock in settlement of $20,000 of convertible debt.
In October 2014, the Company issued 1,293,103 shares of its common stock in settlement of $15,000 of convertible debt.
In October 2014, the Company issued 2,260,764 shares of its common stock in settlement of $18,000 of convertible debt and accrued interest of $2,120.
In October 2014, the Company issued 552,846 shares of its common stock in settlement of $5,500 of convertible debt and accrued interest of $1,300.
In October 2014, the Company issued an aggregate 2,773,549 shares of common stock for consulting services.
In October 2014, the Company issued 538,875 shares of common stock in settlement of accounts payable."
Same 10-Q, PAGE 4 shows they still owe "related party debt" aka insiders being owed for "notes" and "loans" cause the company didn't pay um in cash or they apparently lent the company cash I guess- over $2.3 MILLION (that's in addition to the $1.5 million that Brenda Leonhardt is now suing for which is one line above as "subordinated related party debt")
PAGE 4, 10-Q table Liabilities and Stockholder's Deficit:
Notes payable, related party $2,377,271
(they owed um about the same in 2013 by the way- so it's not gone or going down cause of "revenues" or whatever)
So again, if they're borrowing from themselves, if they're paying presently owed large "cash" bonuses to 2 "employees" via issuing "notes owed" etc- then what the heck cash do they have to pay some new Sr Mgt position with? Again, makes zero sense to me? I'll be looking in future SEC filings to see if this "new hire" guy shows up and continues to show up and see what and how he's being paid.
Quote: "Ask Mike T"
I'm assuming that's referring to "Mike Tomas" the CEO of Bioheart?
I wasn't aware that the CEO of public traded companies "know" or have ability to "predict" their company's future public traded stock share price at any given time, let alone can be "asked about it" and will be willing to discuss it with the general public?
I thought as a pretty hard, fast rule- that CEO's of public traded companies almost never, ever discuss the price of their public shares, let alone discuss or make future predictions about the share price of their company's public traded shares?
I'd really be surprised if that's the case?
"Are we going to 0.005 USD???"
I don't see any reason why it's not 100% possible given the massive, unending dilution and continual use of toxic, convertible debt type financing (as recent as Oct of 2014, see last filed 10-Q "subsequent financing"- it shows two more toxic "notes" with very steep share discounts of 45% on one and 47% on the other).
The all time low for BHRT is .0066 around Dec 2013. So I don't see why .005 is unreasonable given that the shares have just about doubled via continual dilution since that all time previous low was reached around Dec of 2013.
From the 10-Q filing close to the all time low of .0066 in end of 2013:
"As of November ____, 2013, there were 347,175,310 outstanding shares of the Registrant’s common stock, par value $0.001 per share."
From the recently filed 8-K for the proxy share vote:
"At the Annual of Stockholders (the “Annual Meeting”) of the Company held on February 2, 2015, the stockholders of the Company approved each of the proposals set forth below by the final voting results (based on 610,475,357 common shares and 20,000,000 Series A Preferred Shares with voting rights) set forth below."
That's almost a doubling of the O/S shares (fully diluted shares if higher) - a lot of dilution no matter how one slices it IMO.
Seems a very realistic possibility IMO. No one can predict prices, but given that BHRT hit .0066 when they had far less dilution and have continually used toxic note (floorless financing) since then (Asher, Daniel James, Fourth Man, KBM, Magna see SEC filings), and now this highly dilutive Magna credit line for $3 million which they said they intend to "fully tap" and use- it's gonna be a lot of shares hitting the market IMO.
From last filed 10-Q, PAGE 26 (just to show how recently they took on more toxic, aka "convertible debt" aka "floorless" note financing deals- notorious type of financing often causing share prices to decrease, according to the SEC and numerous other credible source easily found via looking up "convertible debt, floorless note financing" or similar Google search terms)
http://www.sec.gov/Archives/edgar/data/1388319/000114544314001305/d31740.htm
Page 26:
"NOTE 13 — SUBSEQUENT EVENTS
Subsequent financing
KBM Worldwide
On October 6, 2014, the Company entered into a Securities Purchase Agreement with KBM Worldwide, Inc., for the sale of an 8% convertible note in the principal amount of $38,000 (the “Note”).
The Note bears interest at the rate of 8% per annum. All interest and principal must be repaid on July 8, 2015,. The Note is convertible into common stock, at holder’s option, at a 45% discount to the lowest daily trading price of the common stock during the 10 trading day period prior to conversion. In the event the Company prepays the Note in full, the Company is required to pay off all principal and accrued interest at 150%, and any other amounts.
Daniel James Management
On October 3, 2014, the Company entered into a Securities Purchase Agreement with Daniel James Management, Inc., for the sale of a 9.5% convertible note in the principal amount of $25,000 (the “Note”).
The Note bears interest at the rate of 9.5% per annum. All interest and principal must be repaid on October 2, 2015. The Note is convertible into common stock, at holder’s option,In the event the Company prepays the Note in full, the Company is requi at a 47% discount to the lowest daily trading price of the common stock during the 10 trading day period prior to conversion. red to pay off all principal and accrued interest at 150%, and any other amounts."
Notice, that KBM note is due by July 8th, 2015- not far off. So KBM either converts it to shares or BHRT owes um 150% of the face value and interest due. My guess, like all these "notes" is it gets converted to free trading shares. That's a good chunk of dilution if converted anywhere near these present prices.
Remember, the lower the price goes- the more dilutive these "note" financing deals become. That's the danger of those type of "floorless" notes- there is literally no bottom to how low the shares can go and still be converted by the note holder. The note holder actually gets more shares the lower and lower the price goes- often something that works to their advantage.
http://www.sec.gov/answers/convertibles.htm
Where did I ever state I know something the public doesn't know? PLEASE EXPLAIN???
DO YOU KNOW SOMETHING THE PUBLIC DOESN'T? Please explain.
Everything I stated is only what the public does know (including providing links to PUBLIC information sources)- the explanations are what is never given and I CLEARLY stated that's what confuses me- how do these things just never happen (such as "claimed" in PR and other places) then no public explanation is ever given?
http://www.marketwired.com/press-release/bioheart-announces-phase-iii-mirror-trial-for-myocell-initiated-otcqb-bhrt-1807938.htm
For example, that PR "claimed" that MIRROR was a phase 3 trial and was "FULLY FUNDED BY BIOHEART" to take place at numerous locations in a 12 month period, etc. But MIRROR for all intents and purposes then never even took place. MIRROR is then simply "cancelled" and vanishes per a one-liner in a Jan 25th, 2015 "PR" with no further explanation given, after over 1.5 yrs of never actually even happening. It's all public info and seems very confusing to me- it's "claimed" to be a large phase 3 trial, it's "claimed" it's FULLY FUNDED by Bioheart in PUBLIC released documents, but then it never actually even takes place? I sighted numerous other similar public info of other "events" or "claims" first being said to be happening or have happened (usually in PR or a "blog" or some public presentation format), only later to simply vanish, never amount to anything monetarily, never be mentioned again in company SEC filings, etc It's not complicated to follow this pattern IMO. Numerous examples were given and numerous more examples are easily found using Goggle and the company's own SEC filings.
So do you know things the public doesn't know?
Please explain?